Hantz Financial Services’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$69K Buy
2,106
+1,477
+235% +$53.2K ﹤0.01% 1537
2026
Q1
$22K Buy
629
+496
+373% +$20.2K ﹤0.01% 1835
2025
Q4
$5K Sell
133
-31
-19% -$1.35K ﹤0.01% 2133
2025
Q3
$8K Buy
164
+5
+3% +$259 ﹤0.01% 1894
2025
Q2
$8K Buy
+159
New +$8.72K ﹤0.01% 1572

Other funds holding CNMD

Hantz Financial Services's CNMD Position: Q2 2026 in Review

Hantz Financial Services increased its CONMED (CNMD) stake by 235% in Q2 2026, buying an estimated $53.2K and bringing the position to 2,106 shares worth $69K. The position accounts for ﹤0.01% of the portfolio, ranked #1537.

Hantz Financial Services first reported a position in CNMD in Q2 2025 and has held it in 5 quarters since. 247 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Hantz Financial Services held 2,106 shares of CONMED worth $69K as of Q2 2026.
  • Hantz Financial Services bought 1,477 CONMED shares in Q2 2026, an estimated $53.2K.
  • CONMED made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #1537 holding.
  • Hantz Financial Services first reported a position in CONMED in Q2 2025 and has held it in 5 quarters since.
  • 247 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.